Pharma Journalist -

MaxCyte, Inc. announced the signing of a strategic platform license (SPL) with Catamaran Bio, Inc., a biotechnology company developing novel, off the-shelf chimeric antigen receptor…
Read More...

Gilead Sciences, Inc. and EVOQ Therapeutics, Inc. (EVOQ) announced a collaboration and licensing agreement to advance EVOQ’s proprietary technology for the treatment of rheumatoid…
Read More...

Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, and Abiosciences, the single-cell bioinformatics leader, announced a new partnership to co-develop…
Read More...

Alteogen Inc. announced that the company has entered into an exclusive license agreement with Sandoz AG. Under the terms of the agreement, Sandoz will acquire the world-wide rights to…
Read More...

Alligator Bioscience announces an expansion to its research collaboration and license agreement with Orion Corporation, a global pharmaceutical company based in Finland, to discover and…
Read More...

Merck announced a research collaboration and commercial license agreement with Mersana Therapeutics, Inc., Cambridge, Massachusetts, USA to discover novel antibody-drug conjugates…
Read More...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces a new exclusive licensing and commercialization agreement with Junshi Biosciences, an…
Read More...

Ablaze Pharmaceuticals announced the initiation of a development and manufacturing services agreement with Yonghe Pharmaceutical Technology Co., Ltd. to develop series of targeted…
Read More...

Kala Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted an investigational new drug (IND) application for the company’s lead product…
Read More...

Opus Genetics, a patient-first, clinical-stage gene therapy company developing treatments for inherited retinal diseases, announced it has acquired the rights to two preclinical-stage…
Read More...